Dr. Tabarak A. Qureshi, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 27
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 122
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
FL license ME103416 -
Critical Care Medicine (Internal Medicine) Physician
FL license ME103416 -
Sleep Medicine (Internal Medicine) Physician
FL license ME103416
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- Uf Health Leesburg Hospital Leesburg, FL
Medical groups
- Florida Hospital Medical Group Inc (1,755 clinicians)
- Villages Regional Hospital Physician Services LLC (209 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 122
- Services billed
- 224
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 105 | 70 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 89 | 63 |
| Critical care, first 30-74 minutes | 63 | 35 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 36 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $5,951 in research payments for these studies, mostly to the institutions running them.
- Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)
Paratek Pharmaceuticals, Inc. · Completed · NCT04922554 - ADH-ADHERE REGISTRY
Inspire Medical Systems, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.